Literature DB >> 10617105

Growth factor-mediated stabilization of amyloid precursor protein mRNA is mediated by a conserved 29-nucleotide sequence in the 3'-untranslated region.

L E Rajagopalan1, J S Malter.   

Abstract

Using a cell-free translation system, we previously demonstrated that the turnover and translation of amyloid precursor protein (APP) mRNA was regulated by a 29-nucleotide instability element, located 200 nucleotides downstream from the stop codon. Here we have examined the regulatory role of this element in primary human capillary endothelial cells under different nutritional conditions. Optimal proliferation required a growth medium (endothelial cell growth medium) supplemented with epidermal, basic fibroblast, insulin-like, and vascular endothelial growth factors. In vitro transcribed mRNAs with the 5'-untranslated region (UTR) and coding region of beta-globin and the entire 3'-UTR of APP 751 were transfected into cells cultured in endothelial cell growth medium. Wild-type globin-APP mRNA containing an intact APP 3'-UTR and mutant globin-APP mRNA containing a mutated 29-nucleotide element decayed with identical half-lives (t 1/2 = 60 min). Removal of all supplemental growth factors from the culture medium significantly accelerated the decay of transfected wild-type mRNA (t 1/2 = 10 min), but caused only a moderate decrease in the half-life of transfected mutant mRNA (t 1/2 = 40 min). We therefore conclude that the 29-nucleotide 3'-UTR element is an mRNA destabilizer whose function can be inhibited by inclusion of the aforementioned mixture of growth factors in the culture medium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617105     DOI: 10.1046/j.1471-4159.2000.0740052.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  The regulation of AβPP expression by RNA-binding proteins.

Authors:  Cara J Westmark; James S Malter
Journal:  Ageing Res Rev       Date:  2012-04-05       Impact factor: 10.895

2.  Translational symphony in (hnRNP) C major for APP.

Authors:  Jerome E Lee; Jeffrey Wilusz
Journal:  Nat Struct Mol Biol       Date:  2010-06       Impact factor: 15.369

3.  Modulation of amyloid precursor protein expression reduces β-amyloid deposition in a mouse model.

Authors:  Ayodeji A Asuni; Maitea Guridi; Joanna E Pankiewicz; Sandrine Sanchez; Martin J Sadowski
Journal:  Ann Neurol       Date:  2014-04-28       Impact factor: 10.422

4.  hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies.

Authors:  Eun Kyung Lee; Hyeon Ho Kim; Yuki Kuwano; Kotb Abdelmohsen; Subramanya Srikantan; Sarah S Subaran; Marc Gleichmann; Mohamed R Mughal; Jennifer L Martindale; Xiaoling Yang; Paul F Worley; Mark P Mattson; Myriam Gorospe
Journal:  Nat Struct Mol Biol       Date:  2010-05-16       Impact factor: 15.369

Review 5.  Decoding the non-coding RNAs in Alzheimer's disease.

Authors:  Nicole Schonrock; Jürgen Götz
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

Review 6.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29

7.  Human MicroRNA targets.

Authors:  Bino John; Anton J Enright; Alexei Aravin; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

8.  A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

Authors:  J Stoehlmacher; D J Park; W Zhang; D Yang; S Groshen; S Zahedy; H-J Lenz
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

9.  MicroRNAs can regulate human APP levels.

Authors:  Neha Patel; David Hoang; Nathan Miller; Sara Ansaloni; Qihong Huang; Jack T Rogers; Jeremy C Lee; Aleister J Saunders
Journal:  Mol Neurodegener       Date:  2008-08-06       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.